NuCana plc

NCNA NASDAQ Santé & Biotech Monde US67022C1062
1.91 $
0.26 %

Biopharmaceutique britannique développant de nouveaux traitements contre le cancer et maladies liées au foie.

Performance & Momentum

6 Months 45.10 %
1 Year 92.19 %
3 Years 99.95 %
5 Years 99.99 %

Similar stocks to NuCana plc

Anantys Community

Be the first to share your analysis on NuCana plc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases